U.S., Nov. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07916714) titled 'Breast Cancer Real-World Insights and Decision Guidance Evaluation in Hong Kong' on Oct. 15.
Brief Summary: Breast cancer is the most common cancer affecting women in Hong Kong, but comprehensive real-world evidence on treatment and outcomes remains limited. This retrospective observational study will use Hong Kong Hospital Authority electronic health records, covering approximately 80% of healthcare utilisation, to evaluate around 45,000 adult women treated between 2018 and 2025. The study will describe patient characteristics, treatment patterns, treatment sequences, treatment duration, discontinuation, response, overall survival, ...